Sg Americas Securities, LLC Cytosorbents Corp Transaction History

Sg Americas Securities, LLC

  • $27.6 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 07, 2022
SELL
$4.05 - $8.11 $56,878 - $113,896
-14,044 Closed
0 $0
Q3 2021

Nov 01, 2021
BUY
$7.0 - $9.71 $98,308 - $136,367
14,044 New
14,044 $114,000
Q3 2020

Nov 09, 2020
SELL
$7.37 - $11.54 $138,386 - $216,686
-18,777 Closed
0 $0
Q2 2020

Jul 20, 2020
BUY
$6.28 - $10.59 $50,321 - $84,857
8,013 Added 74.44%
18,777 $186,000
Q1 2020

Apr 30, 2020
BUY
$3.77 - $7.73 $40,580 - $83,205
10,764 New
10,764 $83,000

Others Institutions Holding CTSO

# of Institutions
55
Shares Held
16.9M
Call Options Held
10.1K
Put Options Held
500
View Full List

About Cytosorbents Corp

CTSO Quotes by TradingView
  • Ticker CTSO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 43,577,400
  • Market Cap $51.9M
  • Description
  • Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...
More about CTSO
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email